Loading patent…
AssigneeG-Group LLC
InventorsOlga Ivanovna Burlutskaya, Ramil Rafailevich Rakhmatullin, Tatyana Ivanovna Burtseva, Abay Izhbulatovich Adelshin
Estimating the term…
The invention relates to medicine and specifically to combustiology, to surgery, and to cosmetology and can be used as a bioplastic material for replacing defects in epithelial tissues (protecting against evaporation and infection) and for stimulating regeneration. The technical result is increased efficacy in healing wounds. The goal is achieved in that a histo-equivalent bioplastic material is used which includes a substrate in the form of a matrix, the material for which is a native form of hyaluronic acid, distinguished in that the histo-equivalent bioplastic material contains a 1.5% solution of hyaluronic acid and a 5% solution of a peptide complex which are mixed until a viscous elastic gel is formed, situated in the foundation and subjected to ultraviolet photopolymerization in a biosafety cabinet over the course of 5-7 hours at the following quantitative ratio in ml: 1.5% solution of hyaluronic acid solution: 80-90%; 5% solution of peptide complex: 10-20%; the finished material has perforations and notches.
A histo-equivalent bioplastic material, comprising a base in the form of matrix, for which the native form of hyaluronic acid is used as the material, characterized in that the histo-equivalent bioplastic material contains 1.5% hyaluronic acid solution and 5% peptide complex solution, that are mixed to form viscous elastic gel placed in a bed and exposed to ultraviolet photopolymerisation in a laminar flow hood for 5-7 hours, at the following quantitative ratio, ml:
Dependencies are inferred from the claim text.